Title of Outcome Measure (Improvement Target): IT-3.3: Diabetes 30-Day Readmission Rate Unique RHP outcome identification number(s): 094109802.3.3 Outcome Measure Description: To achieve improvement under this metric, LPDS will engage in project planning during DY 2. In DY 3, LPDS will apply the planning developed in DY 2 in order to determine baseline rates for future DYs. In DY 4, LPDS intends to improve its diabetes 30-day readmission rate by at least 2.5% over the baseline recorded in DY 3. In DY 5, LPDS intends to improve its diabetes 30-day readmission rate by at least 2.5% over the DY 4 measurement. Process Milestones: DY2: o P-1 – Project planning – engage stakeholders, identify current capacity and needed resources, determine timelines and document implementation plans DY3: o P-2 – Establish baseline rates Outcome Improvement Targets for each year: DY4: o IT-3.3: Diabetes 30-day readmission rate—2.5% improvement over DY3 DY5: o IT-3.3: Diabetes 30-day readmission rate—2.5% improvement over DY4 Rationale: According to the Medicare Payment Advisory Committee, 76 percent of re-hospitalizations occurring within 30 days in the Medicare population are potentially avoidable. Other populations affected include patients with chronic diseases, complex medical and social needs and patients with little or no funding resources for post-acute care needs. Evidence suggests that the rate of avoidable re-hospitalization for diabetes patients can be reduced when a diabetes patient registry is successfully implemented to allow better management of patients’ diabetes-related conditions. A measurable reduction in LPDS’s diabetes 30-day readmission rate will indicate that LPDS has made progress towards these goals. In order to record this reduction, LPDS must first engage in planning and baseline measurement in DYs 2 and 3, respectively. Outcome Measure Valuation: $1,799,011. In determining the value of this outcome measure, LPDS considered the extent to which a reduction in the BH/SA admission rate will address the community’s needs, the population which this improvement will serve, the resources and cost necessary to realize the improvement, and the improvement’s conformity to the goals of the Waiver (including supporting the development of a coordinated care delivery system, improving outcomes while containing costs, and improving the healthcare infrastructure). Specifically, the valuation of this outcome measure takes into account the potential of implementing a hospital-wide diabetes registry to improve quality of care and thereby improve patient outcomes for diabetes patients. The valuation of this outcome measure also takes into account the challenges that LPDS will face in realizing this improvement in the hospital setting. 094109802.3.3 Related Category 1 or 2 Projects:: Starting Point/Baseline: Year 2 (10/1/2012 – 9/30/2013) Process Milestone 1 [P-1]: Project planning—engage stakeholders, identify current capacity and needed resources, determine timelines, and document implementation plans. Data Source: Documentation of project planning Process Milestone 1 Estimated Incentive Payment: $212,474 IT-3.3 HCA Las Palmas Del Sol Year 3 (10/1/2013 – 9/30/2014) Process Milestone 2 [P-2]: Establish baseline rates. Data Source: EHR; claims. Process Milestone 3 Estimated Incentive Payment: $246,286 Diabetes 30-Day Readmission Rate 094109802 094109802.1.3 TBD Year 4 Year 5 (10/1/2014 – 9/30/2015) (10/1/2015 – 9/30/2016) Outcome Improvement Target 1 Outcome Improvement Target 2 [IT-3.3]: Diabetes 30-day [IT-3.3]: Diabetes 30-day readmission rate. readmission rate. Improvement Target: 2.5% Improvement Target: 2.5% improvement over DY3. improvement over DY4. Data Source: EHR; claims. Data Source: EHR; claims. Outcome Improvement Target 1 Estimated Incentive Payment: $395,202 Year 2 Estimated Outcome Year 3 Estimated Outcome Year 4 Estimated Outcome Amount: $212,474 Amount: $246,286 Amount: $395,202 TOTAL ESTIMATED INCENTIVE PAYMENTS FOR 4-YEAR PERIOD: $1,799,011 94614.2 Outcome Improvement Target 2 Estimated Incentive Payment: $945,049 Year 5 Estimated Outcome Amount: $945,049